Use of intramuscular prostaglandin for failure of mid-trimester abortion by another method.
Eight investigators, using a common protocol, studied the use of intramuscular (15S)-15-methyl prostaglandin F2 alpha to abort midtrimester pregnancies which had failed treatment by other methods in 398 cases. Results of treatment of 3 subgroups, defined by reason for primary treatment failure, are presented. The combined efficacy rate was 96.2% with 79.6% of the abortions being complete. The mean time from starting intramuscular therapy to successful abortion was 7.35 hours. The incidence of gastrointestinal side-effects was lower than that previously reported for systemically administered prostaglandins. Serious complications were not appreciably different from those reported for commonly used methods of second trimester abortion except for a slightly higher incidence of excessive bleeding requiring blood replacement. Advantages of this method over currently used methods of treating failures of primary attempts to induce midtrimester abortion by pharmacologic means are discussed.
D000027:Abortion, Incomplete / Q000188:drug therapy; D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D001794:Blood Pressure; D001803:Blood Transfusion; D001831:Body Temperature; D003475:Curettage; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007958:Leukocyte Count; D010388:Pelvis; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011460:Prostaglandins F / Q000008:administration & dosage* / Q000627:therapeutic use; D011674:Pulse; D012119:Respiration; D013396:Suction; D013997:Time Factors
D011460:Prostaglandins F